12.51
Panoramica
Notizia
Cronologia dei prezzi
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Crescent Biopharma Inc Borsa (CBIO) Ultime notizie
What valuation ratios show for Crescent Biopharma Inc. (GKO0) stockM&A Rumor & AI Enhanced Market Trend Forecasts - newser.com
Crescent BiopharmaLighting The Path To The Next Wave Of Cancer Therapies? - RTTNews
What market sentiment indicators show for Crescent Biopharma Inc. (GKO0) stockTrade Analysis Summary & Safe Capital Growth Tips - newser.com
Is Crescent Biopharma Inc. (GKO0) stock a top hedge fund pickTrade Volume Summary & Verified Swing Trading Watchlist - newser.com
Is Crescent Biopharma Inc. (GKO0) stock expanding market penetration2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Will Crescent Biopharma Inc. (GKO0) stock top growth indexes2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Retail Surge: Will Crescent Biopharma Inc. (GKO0) stock beat value stocksJuly 2025 Price Swings & Reliable Price Breakout Alerts - Trung tâm Dự báo KTTV quốc gia
Moving Averages: Can Crescent Biopharma Inc. (GKO0) stock stage a strong rebound this quarter2025 Performance Recap & Stepwise Trade Signal Implementation - Trung tâm Dự báo KTTV quốc gia
TANG CAPITAL MANAGEMENT LLC Increases Stake in Crescent Biopharm - GuruFocus
GlycoMimetics skyrockets on buyout deal - MSN
Crescent Biopharma (NASDAQ:CBIO) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Will Crescent Biopharma Inc. (GKO0) stock beat value stocksJuly 2025 Technicals & Safe Capital Growth Plans - newser.com
GlycoMimetics adjusts merger terms with Crescent Biopharma - MSN
Will Crescent Biopharma Inc. (GKO0) stock benefit from Fed rate cutsJuly 2025 Update & Safe Entry Zone Identification - newser.com
Short Interest in Crescent Biopharma, Inc. (NASDAQ:CBIO) Grows By 103.8% - MarketBeat
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives $25.60 Consensus Target Price from Analysts - Defense World
Will Crescent Biopharma Inc. (GKO0) stock hit Wall Street targetsJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Crescent Biopharma, Inc. (NASDAQ:CBIO) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):